Some studies have also suggested that CSF3R mutations may be effective diagnostic and prognostic markers for chronic neutrophilic leukemia and chronic myeloid leukemia [24, 25]. The gene discussed is CSF3R; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.